DV
Dividend Vision

RANI — Rani Therapeutics Holdings Inc

Rani Therapeutics Holdings Inc (RANI)

Total return is -92.8% over the past 5 years, 182.2 points behind SPY at 89.4%. Its deepest 1-year drawdown was 77.8%.

RANI is an equity stock fund focused on Rani Therapeutics Holdings Inc, a specialty pharmaceutical company. The fund does not currently offer dividend distributions, making it a non-yielding equity holding with no listed expense ratio or asset management data available. This fund structure appeals primarily to growth-oriented investors seeking exposure to the therapeutic pharmaceuticals sector rather than income-focused investors.

RANI key facts

Asset type
Stock
Asset class
Equity
Inception date
07/30/2021
Last close
$0.80
Market cap
$95,001,240
Average volume
885900.0
Beta
0.795
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.28